LOADING
Comparing Coca-Cola Company (KO) and Thermo Fisher Scientific (TMO) across the Consumer Staples and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | KO | TMO |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $359.2B | $195.9B |
| P/E Ratio | 26.3 | 29.0 |
| Forward P/E | 25.7 | 21.2 |
| PEG Ratio | 4.28 | 1.74 |
| EPS | $3.18 | $18.18 |
| Revenue Growth (YoY) | 12.1% | 6.2% |
| Profit Margin | 27.8% | 15.1% |
| Return on Equity | 43.4% | 13.5% |
| Dividend Yield | 2.49% | 0.34% |
| Beta | 0.35 | 0.87 |
| 52-Week High | $85.68 | $642.71 |
| 52-Week Low | $64.04 | $401.89 |
| Volume | -- | -- |
Coca-Cola Company is the larger company by market capitalization. Coca-Cola Company trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Coca-Cola Company offers a higher dividend yield for income investors. Coca-Cola Company has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.